Overview
Autosomal recessive ataxia due to PEX10 deficiency (also known as peroxisomal biogenesis disorder complementation group 7, or PEX10-related cerebellar ataxia) is a rare neurological condition caused by biallelic mutations in the PEX10 gene. The PEX10 gene encodes a peroxisomal membrane protein essential for peroxisome biogenesis and function. Peroxisomes are cellular organelles involved in the metabolism of very long-chain fatty acids, bile acid synthesis, and other critical biochemical pathways. Mutations in PEX10 can produce a spectrum of disease severity, ranging from severe neonatal forms within the Zellweger spectrum disorders to milder phenotypes presenting primarily as cerebellar ataxia in childhood or adulthood. In the milder ataxia-predominant form (Orphanet 247815), the primary body system affected is the central nervous system, particularly the cerebellum. Key clinical features include progressive cerebellar ataxia (impaired coordination and balance), sensorimotor neuropathy, and cerebellar atrophy visible on brain MRI. Patients may also experience hyperreflexia, dysarthria (slurred speech), oculomotor abnormalities, and cognitive difficulties. Some individuals may have subtle biochemical abnormalities of peroxisomal function, such as mildly elevated very long-chain fatty acids or abnormal phytanic acid levels, which can aid in diagnosis. There is currently no curative treatment for autosomal recessive ataxia due to PEX10 deficiency. Management is supportive and symptomatic, focusing on physical therapy and rehabilitation to maintain mobility and coordination, speech therapy for dysarthria, and occupational therapy for daily living activities. Monitoring of peroxisomal biochemical markers and neurological status is recommended. Genetic counseling is important for affected families. Research into peroxisomal disorders continues, but no disease-modifying therapies are currently available for this condition.
Also known as:
Clinical phenotype terms— hover any for plain English:
Autosomal recessive
Passed on when both parents carry the same gene change; often skips generations
Variable
Can begin at different ages, from infancy through adulthood
Treatments
No FDA-approved treatments are currently listed for Autosomal recessive ataxia due to PEX10 deficiency.
View clinical trials →Clinical Trials
View all trials with filters →No actively recruiting trials found for Autosomal recessive ataxia due to PEX10 deficiency at this time.
New trials open frequently. Follow this disease to get notified.
Specialists
View all specialists →No specialists are currently listed for Autosomal recessive ataxia due to PEX10 deficiency.
Treatment Centers
8 centersBaylor College of Medicine Rare Disease Center ↗
Baylor College of Medicine
📍 Houston, TX
🏥 NORDStanford Medicine Rare Disease Center ↗
Stanford Medicine
📍 Stanford, CA
🔬 UDNNIH Clinical Center Undiagnosed Diseases Program ↗
National Institutes of Health
📍 Bethesda, MD
🔬 UDNUCLA UDN Clinical Site ↗
UCLA Health
📍 Los Angeles, CA
🔬 UDNBaylor College of Medicine UDN Clinical Site ↗
Baylor College of Medicine
📍 Houston, TX
🔬 UDNHarvard/MGH UDN Clinical Site ↗
Massachusetts General Hospital
📍 Boston, MA
🏥 NORDMayo Clinic Center for Individualized Medicine ↗
Mayo Clinic
📍 Rochester, MN
👤 Mayo Clinic Center for Individualized Medicine
🏥 NORDUCLA Rare Disease Day Program ↗
UCLA Health
📍 Los Angeles, CA
Travel Grants
No travel grants are currently matched to Autosomal recessive ataxia due to PEX10 deficiency.
Community
No community posts yet. Be the first to share your experience with Autosomal recessive ataxia due to PEX10 deficiency.
Start the conversation →Latest news about Autosomal recessive ataxia due to PEX10 deficiency
No recent news articles for Autosomal recessive ataxia due to PEX10 deficiency.
Follow this condition to be notified when news becomes available.
Caregiver Resources
NORD Caregiver Resources
Support, advocacy, and financial assistance for caregivers of rare disease patients.
Mental Health Support
Rare disease caregiving can be isolating. Connect with counseling and peer support.
Family & Caregiver Grants
Financial assistance programs specifically for caregivers of rare disease patients.
Social Security Disability
Learn how rare disease patients may qualify for SSDI/SSI benefits.
Common questions about Autosomal recessive ataxia due to PEX10 deficiency
What is Autosomal recessive ataxia due to PEX10 deficiency?
Autosomal recessive ataxia due to PEX10 deficiency (also known as peroxisomal biogenesis disorder complementation group 7, or PEX10-related cerebellar ataxia) is a rare neurological condition caused by biallelic mutations in the PEX10 gene. The PEX10 gene encodes a peroxisomal membrane protein essential for peroxisome biogenesis and function. Peroxisomes are cellular organelles involved in the metabolism of very long-chain fatty acids, bile acid synthesis, and other critical biochemical pathways. Mutations in PEX10 can produce a spectrum of disease severity, ranging from severe neonatal forms
How is Autosomal recessive ataxia due to PEX10 deficiency inherited?
Autosomal recessive ataxia due to PEX10 deficiency follows a autosomal recessive inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.